P3 Health Partners Inc. (PIII): Nasdaq/NYSE listing notice — P3 Health Partners regains Nasdaq compliance on Listing Rule 5550(b)(2)

P3 Health Partners Inc.

Received Nasdaq letter on May 20, 2026 confirming compliance with continued listing standards.
Compliance determination based on Company's Form 8-K filed May 15, 2026.
Previously disclosed non-compliance with Nasdaq Listing Rule 5550(b) on November 28, 2025.
Company now satisfies the $35 million market value of listed securities requirement under Rule 5550(b)(2).

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

P3 Health Partners Inc. received a nasdaq compliance regained notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

May 20, 2026, the Company received a letter from the Staff notifying the Company that, based on the Company’s Form 8-K filed with the SEC on May 15, 2026, the Staff has determined that the Company complies with Nasdaq Li

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001832511-26-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.